Journal Article

Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-C

Siciliano, Gabriele, Unti, Elisa, Ceravolo, Roberto, Del Prete, Eleonora, Bellini, Gabriele, Frosini, Daniela

2021

Overview

Background Spastic Paraplegia type 7 (SPG7) is one of the most common autosomal recessive Hereditary Spastic Paraplegias (HSP); Spastic Paraplegias (SPGs) can present as hereditary ataxias. However, ataxia is frequently the symptom of presentation of many other hereditary/sporadic disorders, such as Multiple system atrophy type C (MSA-C), an α-synuclein sporadic neurodegenerative disorder, in which cerebellar ataxia is one of the main clinical features. Dopamine Transporter imaging (DAT-SCAN), associated with clinical features, can be a helpful tool in order to distinguish MSA-C from other causes of ataxia. Case-presentation We present the case of a 70-year-old man with gait difficulties over a period of 3 years and frequent backward/lateral falls. He also reported urinary urge incontinence, but no symptoms that are compatible with orthostatic hypotension. On neurological examination he showed ataxic gait, spasticity in the left lower limb and trunk and limb ataxia, especially on the left side. Mild hypokinesia was found in all 4 limbs, especially in the left foot. MRI revealed atrophy of the cerebellar hemispheres and vermis. DAT-SCAN imaging revealed bilateral nigro-striatal degeneration, which was compatible with a diagnosis of possible MSA-C. Considering the atypical disease course (the patient walked without any support after 3 years), we carried out a genetic investigation for Ataxia, and a mutation in SPG7 was found. Conclusions DAT-SCAN imaging, evaluated together with the clinical findings, can be useful for differentiating MSA from other possible causes of adult-onset Ataxia. Indeed, patients with MSA-C generally show a decreased uptake of dopamine transporters in DAT-SCAN imaging. Ours is the first case reported in the literature of a patient with SPG7 mutation with nigrostriatal degeneration and a clinical presentation of a possible MSA-C. Performing genetic investigations in patients with an atypical disease course is important to avoid MSA-mimicries. Identifying the correct diagnosis is important not only for prognostic reasons, but also for possible future genetic therapies.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Ataxia / Atrophy / Case Report / Case studies / Cerebellar ataxia / Cerebellum / CT imaging / DAT-SCAN imaging / Diagnosis / Diagnosis, Differential / Dopamine transporter / Dysarthria / Gait / Genes / Hereditary spastic paraplegia / Hypotension / Magnetic resonance imaging / Medicine / Medicine & Public Health / Mimicry / Mitochondrial DNA / Movement disorders / Multiple system atrophy / Mutation / Neostriatum / Neurochemistry / Neurodegeneration / Neurodegenerative diseases / Neurology / Neurosurgery / Nigrostriatal denervation / Paralysis, Spastic / Parkinson's disease / Patients / Proteins / Spasticity / SPG7 / Synuclein